Royalty Pharma plc (NASDAQ:RPRX) Q3 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter Earnings Conference Call.
Repros Therapeutics Inc. (RPRX)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
15 Biggest European Pharmaceutical Companies
Alongside the United States, Europe has some of the most advanced industries and economies in the world.
5 Best Blue Chip Stocks to Buy According to Phill Gross and Robert Atchinson's Adage Capital
In this piece, we’ll take a look at the 5 Best Blue Chip Stocks to Buy According to Phill Gross and Robert Atchinson's Adage Capital.
Warren Buffett is Decreasing Stakes in These 3 Stocks
In this article, we discuss the 3 stocks that Warren Buffett is decreasing stakes in.
10 Dividend Stocks to Buy According to Andreas Halvorsen's Viking Global
In this article, we discuss the dividend stocks to buy according to Andreas Halvorsen's Viking Global.
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, John Paulson, Citadel LLC, Tiger Global Management, Royalty Pharma PLC (RPRX), Nicolet Bankshares Inc (NCBS), and More
Billionaire hedge fund manager Bill Ackman asserted on Tuesday that the United States Federal Reserve needs to tackle inflation in an aggressive manner or face a market crash and "destruction" of demand...
Warren Buffett is Selling These 3 Stocks in 2022
Royalty Pharma plc (NASDAQ:RPRX) is a New York-based firm that buys biopharmaceutical royalties and funds innovations in the biopharmaceutical industry in the United States.
5 Best Dividend Stocks According to Andreas Halvorsen's Viking Global
In this article, we discuss the 5 best dividend stocks according to Andreas Halvorsen's Viking Global.
Warren Buffett Is Selling These 10 Stocks
Value investors have once again come into the spotlight as inflation batters growth stocks.
10 Best Healthcare Stocks To Buy In 2022
The post-COVID world has highlighted several existing and emerging healthcare trends, such as shifting consumer preferences, the collaboration of life sciences and healthcare, new digital health technologies...
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
